期刊文献+

肝硬化门静脉血栓形成危险因素分析 被引量:2

Risk factors of portal vein thrombosis in cirrhosis
下载PDF
导出
摘要 目的:研究肝硬化患者门静脉血栓形成(PVT)的相关危险因素。方法:本研究前瞻性共纳入肝硬化患者149例,其中50例合并PVT为肝硬化PVT组,另有99例为肝硬化无PVT组。记录临床资料包括肝硬化病因和Child-Pugh分级;除常规实验室检查外,还监测凝血四项、D-二聚体、抗凝血酶-Ⅲ(ATⅢ)和蛋白C(PC)等。采用非条件Logistic回归分析筛选出相关危险因素。结果:单因素检验显示肝硬化PVT组的血液D-二聚体和血小板(PLT)水平明显高于无PVT组(P<0.05),而两组AT-Ⅲ、PC血清水平相近,差异无统计学意义(P>0.05)。非条件Logistic回归分析结果显示D-二聚体与肝硬化PVT呈正相关(P<0.001,OR=1.275);而PLT与PVT相关性并无统计学意义(P>0.05)。结论:高血D-二聚体是肝硬化PVT的相关危险因素。 Objective: To investigate the risk factors for portal vein thrombosis( PVT) in cirrhotic patients.Methods: A total of 149 cirrhotic patients were prospectively enrolled in this study. Among them,50 patients with PVT were assigned to the PVT group and 99 without PVT to the non-PVT group. The clinical data were recorded including the cause of cirrhosis and Child-Pugh classification. In addition to routine laboratory tests,the four-item coagulation functions,D-dimer,antithrombin-III( AT-III) and protein C( PC) levels were determined. Nonconditional Logistic regression analysis was used to screen for the potential risk factors. Results: Univariate analysis showed that the levels of blood D-dimer and platelet( PLT) in the PVT group were significantly higher than those in the non-PVT group( P<0.05),but the serum levels of AT-III and PC in the two groups were similar without statistical difference( P > 0. 05). Non-conditional Logistic regression analysis showed that D-dimer was positively correlated with PVT in cirrhosis( P<0.001,OR = 1.275). There was no significant correlation between PLT and PVT( P>0.05). Conclusion: High blood level of D-dimer is a risk factor for PVT in cirrhosis.
出处 《广州医科大学学报》 2017年第5期18-21,共4页 Academic Journal of Guangzhou Medical University
关键词 肝硬化 门静脉血栓形成 D-二聚体 抗凝血酶-Ⅲ 蛋白C 危险因素 cirrhosis portal vein thrombosis D-dimer antithrombin-Ⅲ protein C risk factor
  • 相关文献

参考文献2

二级参考文献9

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:271
  • 2Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89:279-286.
  • 3Mangia A, Villani MR, Cappucci G, Santoro R, Ricciardi R, Facciorusso D, Leandro G, Caruso N, Andriulli A. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17:745-751.
  • 4Romero Gomez M, Suarez Garcia E, Lopez Lacomba D, Marchante I, Grande L, Castro Fernandez M. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2000; 31:237-240.
  • 5Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, Ames PR, Balzano A. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31:345-348.
  • 6Erkan O, Bozdayi AM, Disibeyaz S, Oguz D, Ozcan M, Bahar K, Karayalcin S, Ozden A, Bozkaya H, Yurdaydin C, Uzunalimoglu O. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2005; 17: 339-343.
  • 7Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Hepatology 1993; 17:78-83.
  • 8Romero-Gomez M, Gutierrez-Tous R, Delgado-Mije D. Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology 2002; 122: 2095.
  • 9中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14013

共引文献434

同被引文献33

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部